LYNCH TIMOTHY P enters AEON BIOPHARMA, INC. with 5.35M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/21/2026ACC: 0000935836-26-000438
5.35M
Baseline shares
100% direct
5.35M
Direct ownership
1 position
7M
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Class A Common Stock
DirectShares owned5.35M
Total
5.35M direct5.35M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 5.35M | Direct |
| Total | 5.35M | 5.35M direct |
Derivative Holdings3
Pre-Funded Warrants
DirectUnderlying security
Class A Common Stock
Underlying shares
1M
Shares owned
N/A
Exercise price
0.0001
Expiration
—
Exercise window
—
Warrants
DirectUnderlying security
Class A Common Stock
Underlying shares
3M
Shares owned
N/A
Exercise price
0.3704
Expiration
—
Exercise window
—
Warrants
DirectUnderlying security
Class A Common Stock
Underlying shares
3M
Shares owned
N/A
Exercise price
0.3221
Expiration
—
Exercise window
—
Total
Underlying
7M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Pre-Funded Warrants Direct | Class A Common Stock | 0.0001 | — | — | 1M | N/A |
| Warrants Direct | Class A Common Stock | 0.3704 | — | — | 3M | N/A |
| Warrants Direct | Class A Common Stock | 0.3221 | — | — | 3M | N/A |
| Total | 7M | 0.00 | ||||